INTERNATIONAL PATENT: HACKENSACK MERIDIAN HEALTH, INC. FILES APPLICATION FOR "MOLECULAR ENGINEERING TO ENHANCE CHIMERIC ANTIGEN RECEPTOR-MEDIATED TUMOR IMMUNOTHERAPY"

GENEVA, April 29 -- HACKENSACK MERIDIAN HEALTH, INC. (343 Thornall StreetEdison, NJ 08837) filed a patent application (PCT/US2025/025517) for "MOLECULAR ENGINEERING TO ENHANCE CHIMERIC ANTIGEN RECEPTOR-MEDIATED TUMOR IMMUNOTHERAPY" on Apr 21, 2025. With publication no. WO/2026/084743, the details related to the patent application was published on Apr 23, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): XUE, Hai-hui (109 Mountainview AveNutley, NJ 07110), ZHANG, Yi (208 Sykes LaneWallingford, PA 19086), PERLIN, David (60 Sutton Place South, Apt 14gnEdison, NY 10022), ZHAO, Xin (9 Market St.Cli...